Love Lifesciences is advancing care through responsible innovation— learning fast, acting ethically, and delivering solutions that genuinely improve patient lives.
Mission:
Revolutionize the patient experience to ensure all patients are given the opportunity to Love Life
2021
Love Lifesciences founded by Nick Love, MD, MBA and Bradley Hopper after witnessing patient non-compliance
2022
Prototype UNIPEN developed;
UNIPEN patents & trademarks filed
2023
ISO, FDA Guidance & Human Factors testing performed on UNIPEN;
Commercial strategy developed & initiated
2024
FDA determination letter received;
APC strategic partnership announced
2025
UniPen Limited Market Release (LMR) launched;
Semi-Automated Tabletop Fill-Finish System developed, patents filed & launched with LMR partner
2026
Official Full Market Launch of UniPen and Tabletop Fill-Finish System
Every decision starts with the patient, ensuring Love Lifesciences' products measurably enhance their experience and outcomes.
Agility is in the Love Lifesciences DNA, enabling our team to seize new opportunities and outmaneuver entrenched competitors.
We conduct all operations with uncompromising integrity, honoring the trust of patients, colleagues, and investors alike.
We grow faster by rigorously extracting lessons from every win, misstep, and shared experience.
Meeting regulations is the baseline; we intentionally outperform industry benchmarks to deliver superior outcomes and exceptional value.
We embed creative problem-solving across product & business so each challenge results in breakthroughs that amplify impact.
CEO, Co-Founder
Background in Biopharma Business Analytics & Research
Board Member – BioKansas
Advisory Board Member – KU School of Medicine
CTO, Co-Founder
10y+ founding & growing companies in various industries
Background in Product Design & Engineering
Chief Operations Officer
10y+ founding, building, and supporting biosciences and deep-tech startups
Head of Growth Strategy
20y+ in MedTech commercial & market development strategy leadership for Johnson & Johnson, Pfizer
Head of Regulatory Affairs
35y+ Medical Device expertise including executive management, engineering, regulatory affairs
Kyle Gillett, MD
Founder of Gillett Health Medical Spa & Concierge Care
Specializes in Obesity Medicine & Hormone Replacement Therapy
Brian Williamson, PharmD
Previous Founder & Owner of JCB Laboratories, 503B Pharmacy sold to Fagron
Rick Couldry, PharmD
Chief Pharmacy Officer / VP of Health Professions at The University of Kansas Health System
Built >$500M ARR Specialty Pharmacy
Selina Gierer, DO
Director of Allergy & Immunology at the University of Kansas Health System
Dan Aires, MD, JD
Prior Director of Division in Dermatology at The University of Kansas Hospital System
CEO & Co-Founder of Kanpecia Biotech
Tom Krol, PharmD
30y+ Experience in Pharma/Biotech including strategy development, drug development
Lisa Friis, PhD
Director of Product Development Core at KU
CTO DirectSync Surgical
Nancy Forlenza
20y+ in Pharma Sales Management including startup experience
Launched & sold injectable products including TRT
Jason Andrews
CEO at GemTech Manufacturing
Prior Owner/CEO of GroupSource GPO
20y+ in medical device sales
Bryce Davis
CEO at Data Insights
CEO at Karte Payments & Managing Partner PayCloud innovations
Dave Van Brunt
25y+ Experience as Marketing Director & VP of Marketing at GSK and Bayer
Kevin Lockett
Board Member – The University of Kansas Health System and Kansas City University
Managing Partner, Fulcrum Global Capital
Robin Love
20y+ in Pharma/Medical Device Sales Management at J&J, Pfizer, and Novartis
Launched & sold multiple injectable products